Pursuing healthier lives through
the development of microbiome-based
therapeutic solutions.

ATOGEN believes in the transformative potential of the human microbiome
and develops safe and effective therapeutic solutions by integrating a
robust functional strain discovery platform with its extensive in-house R&D expertise.

Scroll down

ABOUT US

We develop innovative microbiome-based therapeutics and scientifically validated health products to address a wide range of diseases and promote everyday well-being.

Within the tiny universe inside us, we discover new paths to healing.
We develop optimized cultivation processes by assessing strain-specific productivity and stability.
ATOGEN is committed to advancing microbiome drug development without compromise
We elucidate therapeutic mechanisms through integrative multi-omics analysis of genomics, transcriptomics, and metabolomics
Beyond probiotics — leading the global microbiome therapeutics market.

Research & Development

Varified R&D Capabilities
of ATOGEN
Through its in-house R&D, ATOGEN has demonstrated
strong technological capabilities by delivering
tangible results in two key areas: microbiome-based
therapeutics and functional health ingredients.

PRODUCTS

ATOGEN develops only
high-performance probiotics
with verified safety.